wpdd793456.png
wp240b0238.png

Sign our

Petition!

It is our right

to choose

treatments.

wpe12fba7d.png

Donate!

Provide

support with

your tax

deductible

donations.

wpd96d770e.png

Join

Us!

Become

a Proventus

team member.

wp75d83345.png













Improving Life  Increasing Hope


wpda2c881c.png
wp74980d62.png

French judges probe firms over vaccinations

PARIS, Jan 31 08 (Reuters) - French authorities have opened a formal investigation into two managers from drugs groups GlaxoSmithKline and Sanofi Pasteur over a vaccination campaign in the 1990s, a judicial source said late on Thursday.

Judge Marie-Odile Bertella-Geffroy also opened an investigation for manslaughter against Sanofi Pasteur MSD, a joint venture between Sanofi Aventis and Merck the same source said.

The investigations follow allegations that the companies failed to fully disclose side effects from an anti-hepatitis B drug used in a vaccination campaign between 1994 and 1998.

There was no immediate comment from the companies or the two managers involved.

From 1994 to 1998, almost two thirds of the French population and almost all newborn babies were vaccinated against hepatitis B, but the campaign was suspended after concerns arose about possible secondary effects from the treatments.

Some 30 plaintiffs have launched a civil action in the case, including the families of five people who died after vaccination. (Reporting by Thierry Leveque; Writing by James Mackenzie; Editing by David Holmes)

Source: Reuters Feb 2008 http://www.reuters.com

Comment                                                                                  If these allegations are true, and considering that we are given to understand by the medical community and some charities, that trials and the data from such trials which underlines the safety and efficacy of the proposed drug are the gold standard, what happens next? (This is not the only case).

2007

The use of the Internet to scam the innocent

50 billion e-mails are sent around the world each day, experts estimate that spam now accounts for 90% of e-mails. Nearly 50% of which refer to health matters, from advertising drugs to offers of cheap shares that turn out to be virtually worthless, (generally referred to as penny or five cent shares).

 

Jonathan Zittrain, chairman of Internet governance and regulation at Oxford University, and is an Oxford University academic, analysed more than 25,000 items of stock tout spam from a single box.

 

According to the analysis, if the spammer invested $10,000 in touted penny / 5 cent shares they could make $133,000 across several two day periods. The average loss to the victims being 8%.

 

An analyst at “Sophos” (the computer security company), Graham Cluley, said “in some campaigns the share price rose by as much as 600%. Stocks touted are “penny stocks” costing 50 cents per share, listed on exchanges in the US.

 

Some companies appear to have been deliberately created to lure investors with promises of imminent breakthroughs in medicines,  technology or mining.

 

The health market is being targeted;

It is recognised that people compromised by disease use the Internet to gain information about their disease, and to chat with fellow sufferers.

 

Medications may be offered without proper evidence, unsubstantiated claims are made regarding medications, testimonials are posted onto web sites, and then removed, treatment is offered in obscure places.

 

A couple from Connecticut, have been charged by the US Securities and Exchange Commission after making

$1 million from 288 million shares from  penny stocks.

 

Chat room sites are targeted to obtain e-mail addresses and to create an awareness of “penny share” stock, with the intent to encourage others to purchase shares.

 

Some people enter chat rooms pretending to be patients or friends when they are in reality, actively involved in a scam

 

A survey by the FSA of 100 victims found the average loss per person to be £20,000.

 

The bottom line is this;

Any drug has to be approved by an authorised government regulatory agency.

 

There are recognised standards set by the regulatory agency referred to as good manufacturing practice (GMP).

 

When considering any medication ask yourself this.

 

Which regulatory agency has licensed the product?

 

Has GMP approval been given to the product?

 

What medical insurance cover is offered with this treatment?

 

What follow up and aftercare is there?

 

Where, and by whom is the medication manufactured?

 

If it is an animal product, is the country of origin approved and disease free?

 

Over many years people with disease have been offered hope, only to have their hopes dashed, unscrupulous people target them and manipulate their vulnerability to profit from their hope.

 

It is your health you are after.

It is your wealth they are after?

 

 

 

 

There is no reason that good cannot triumph over evil, the problem is that the good people of this world would have to get organised along the lines of the Mafia to make it happen!